▶ 調査レポート

ICAD(頭蓋内アテローム性動脈硬化症)病態の世界市場2018

• 英文タイトル:Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Report 2018

QYResearchが調査・発行した産業分析レポートです。ICAD(頭蓋内アテローム性動脈硬化症)病態の世界市場2018 / Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Report 2018 / D100384資料のイメージです。• レポートコード:D100384
• 出版社/出版日:QYResearch / 2018年10月
• レポート形態:英文、PDF、101ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User License¥416,000 (USD4,000)▷ お問い合わせ
  Enterprise License¥832,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、ICAD(頭蓋内アテローム性動脈硬化症)病態の世界市場について調査・分析し、ICAD(頭蓋内アテローム性動脈硬化症)病態のメーカー別販売量、市場シェア分析、種類別販売分析(ステント、PTAバルーン)、用途別販売分析(病院、診療所、その他)、地域別販売分析(米国、中国、欧州、日本、東南アジア、インド)、価格動向、企業動向、ICAD(頭蓋内アテローム性動脈硬化症)病態産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・ICAD(頭蓋内アテローム性動脈硬化症)病態市場概要
・ICAD(頭蓋内アテローム性動脈硬化症)病態のメーカー別販売量・メーカー別シェア
・ICAD(頭蓋内アテローム性動脈硬化症)病態の世界市場:種類別販売量(ステント、PTAバルーン)
・ICAD(頭蓋内アテローム性動脈硬化症)病態の世界市場:用途別販売量(病院、診療所、その他)
・ICAD(頭蓋内アテローム性動脈硬化症)病態の世界市場:地域別販売量・市場シェア
・ICAD(頭蓋内アテローム性動脈硬化症)病態の米国市場規模
・ICAD(頭蓋内アテローム性動脈硬化症)病態の中国市場規模
・ICAD(頭蓋内アテローム性動脈硬化症)病態の欧州市場規模
・ICAD(頭蓋内アテローム性動脈硬化症)病態の日本市場規模
・ICAD(頭蓋内アテローム性動脈硬化症)病態の東南アジア市場規模
・ICAD(頭蓋内アテローム性動脈硬化症)病態のインド市場規模
・ICAD(頭蓋内アテローム性動脈硬化症)病態のメーカー別分析(企業概要、事業概要、製品概要、収益、価格等)
・ICAD(頭蓋内アテローム性動脈硬化症)病態のコスト分析・価格動向
・ICAD(頭蓋内アテローム性動脈硬化症)病態の産業チェーン(サプライチェーン分析)
・ICAD(頭蓋内アテローム性動脈硬化症)病態のマーケティング戦略・販売チャネル、流通業者
・ICAD(頭蓋内アテローム性動脈硬化症)病態市場への影響要因分析
・ICAD(頭蓋内アテローム性動脈硬化症)病態の世界市場予測
・ICAD(頭蓋内アテローム性動脈硬化症)病態の米国市場予測
・ICAD(頭蓋内アテローム性動脈硬化症)病態の中国市場予測
・ICAD(頭蓋内アテローム性動脈硬化症)病態の欧州市場予測
・ICAD(頭蓋内アテローム性動脈硬化症)病態の日本市場予測
・ICAD(頭蓋内アテローム性動脈硬化症)病態の東南アジア市場予測
・ICAD(頭蓋内アテローム性動脈硬化症)病態のインド市場予測
・ICAD(頭蓋内アテローム性動脈硬化症)病態の種類別世界市場予測(ステント、PTAバルーン)
・ICAD(頭蓋内アテローム性動脈硬化症)病態の用途別世界市場予測(病院、診療所、その他)
...

This report studies the global ICAD (Intracranial Atherosclerotic Disease) Pathology market status and forecast, categorizes the global ICAD (Intracranial Atherosclerotic Disease) Pathology market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).
Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries.
The classification of ICAD (Intracranial Atherosclerotic Disease) Pathology includes Stent and PTA Balloon, and the proportion of Stent in 2017 is about 80.15%.

ICAD (Intracranial Atherosclerotic Disease) Pathology is widely used in Hospital, Clinic and other field. The most proportion of ICAD (Intracranial Atherosclerotic Disease) Pathology is Hospital, and the consumption proportion in 2017 is about 63%.

North America is the largest Sales place, with a Sales market share nearly 26% in 2017. Following North America, Europe is the second largest Sales place with the Sales market share of 20%.

Market competition is intense. Stryker, Balt, TERUMO, MicroPort, Acandis, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

The global ICAD (Intracranial Atherosclerotic Disease) Pathology market is valued at 130 million US$ in 2017 and will reach 260 million US$ by the end of 2025, growing at a CAGR of 8.8% during 2018-2025.

The major players covered in this report
Stryker
Balt
TERUMO
MicroPort
Acandis

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
primarily split into
Stent
PTA Balloon
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hospital
Clinic
Other

The study objectives of this report are:
To analyze and study the global ICAD (Intracranial Atherosclerotic Disease) Pathology sales, value, status (2013-2017) and forecast (2018-2025);
To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
Focuses on the key ICAD (Intracranial Atherosclerotic Disease) Pathology players, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of ICAD (Intracranial Atherosclerotic Disease) Pathology are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturers
ICAD (Intracranial Atherosclerotic Disease) Pathology Distributors/Traders/Wholesalers
ICAD (Intracranial Atherosclerotic Disease) Pathology Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company’s specific needs. The following customization options are available for the report:
Regional and country-level analysis of the ICAD (Intracranial Atherosclerotic Disease) Pathology market, by end-use.
Detailed analysis and profiles of additional market players.

レポート目次

Table of Contents

Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Report 2018
1 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Overview
1.1 Product Overview and Scope of ICAD (Intracranial Atherosclerotic Disease) Pathology
1.2 Classification of ICAD (Intracranial Atherosclerotic Disease) Pathology by Product Category
1.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 primarily split into
1.2.4 Stent
1.2.5 PTA Balloon
1.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market by Application/End Users
1.3.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Other
1.4 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market by Region
1.4.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States ICAD (Intracranial Atherosclerotic Disease) Pathology Status and Prospect (2013-2025)
1.4.3 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Status and Prospect (2013-2025)
1.4.4 China ICAD (Intracranial Atherosclerotic Disease) Pathology Status and Prospect (2013-2025)
1.4.5 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Status and Prospect (2013-2025)
1.4.6 Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Status and Prospect (2013-2025)
1.4.7 India ICAD (Intracranial Atherosclerotic Disease) Pathology Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of ICAD (Intracranial Atherosclerotic Disease) Pathology (2013-2025)
1.5.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2025)
1.5.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2013-2025)

2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Competition by Players/Suppliers, Type and Application
2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Competition by Players/Suppliers
2.1.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology (Volume and Value) by Type
2.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Market Share by Type (2013-2018)
2.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Market Share by Type (2013-2018)
2.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology (Volume and Value) by Region
2.3.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Market Share by Region (2013-2018)
2.3.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Market Share by Region (2013-2018)
2.4 Global ICAD (Intracranial Atherosclerotic Disease) Pathology (Volume) by Application

3 United States ICAD (Intracranial Atherosclerotic Disease) Pathology (Volume, Value and Sales Price)
3.1 United States ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Value (2013-2018)
3.1.1 United States ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
3.1.2 United States ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2013-2018)
3.1.3 United States ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Price Trend (2013-2018)
3.2 United States ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume and Market Share by Players (2013-2018)
3.3 United States ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume and Market Share by Type (2013-2018)
3.4 United States ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume and Market Share by Application (2013-2018)

4 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology (Volume, Value and Sales Price)
4.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Value (2013-2018)
4.1.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
4.1.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2013-2018)
4.1.3 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Price Trend (2013-2018)
4.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume and Market Share by Players (2013-2018)
4.3 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume and Market Share by Type (2013-2018)
4.4 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume and Market Share by Application (2013-2018)

5 China ICAD (Intracranial Atherosclerotic Disease) Pathology (Volume, Value and Sales Price)
5.1 China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Value (2013-2018)
5.1.1 China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
5.1.2 China ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2013-2018)
5.1.3 China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Price Trend (2013-2018)
5.2 China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume and Market Share by Players (2013-2018)
5.3 China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume and Market Share by Type (2013-2018)
5.4 China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume and Market Share by Application (2013-2018)

6 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology (Volume, Value and Sales Price)
6.1 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Value (2013-2018)
6.1.1 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
6.1.2 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2013-2018)
6.1.3 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Price Trend (2013-2018)
6.2 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume and Market Share by Players (2013-2018)
6.3 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume and Market Share by Type (2013-2018)
6.4 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume and Market Share by Application (2013-2018)

7 Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology (Volume, Value and Sales Price)
7.1 Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Value (2013-2018)
7.1.1 Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
7.1.2 Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2013-2018)
7.1.3 Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Price Trend (2013-2018)
7.2 Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume and Market Share by Application (2013-2018)

8 India ICAD (Intracranial Atherosclerotic Disease) Pathology (Volume, Value and Sales Price)
8.1 India ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Value (2013-2018)
8.1.1 India ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
8.1.2 India ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2013-2018)
8.1.3 India ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Price Trend (2013-2018)
8.2 India ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume and Market Share by Players (2013-2018)
8.3 India ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume and Market Share by Type (2013-2018)
8.4 India ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume and Market Share by Application (2013-2018)

9 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Players/Suppliers Profiles and Sales Data
9.1 Stryker
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue, Price and Gross Margin (2013-2018)
9.1.4 Main Business/Business Overview
9.2 Balt
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue, Price and Gross Margin (2013-2018)
9.2.4 Main Business/Business Overview
9.3 TERUMO
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue, Price and Gross Margin (2013-2018)
9.3.4 Main Business/Business Overview
9.4 MicroPort
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue, Price and Gross Margin (2013-2018)
9.4.4 Main Business/Business Overview
9.5 Acandis
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue, Price and Gross Margin (2013-2018)
9.5.4 Main Business/Business Overview

10 ICAD (Intracranial Atherosclerotic Disease) Pathology Maufacturing Cost Analysis
10.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of ICAD (Intracranial Atherosclerotic Disease) Pathology
10.3 Manufacturing Process Analysis of ICAD (Intracranial Atherosclerotic Disease) Pathology

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of ICAD (Intracranial Atherosclerotic Disease) Pathology Major Manufacturers in 2017
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Forecast (2018-2025)
14.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price and Trend Forecast (2018-2025)
14.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Type (2018-2025)
14.3.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Forecast by Type (2018-2025)
14.3.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price Forecast by Type (2018-2025)
14.4 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume Forecast by Application (2018-2025)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer

List of Tables and Figures

Figure Product Picture of ICAD (Intracranial Atherosclerotic Disease) Pathology
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume Comparison (K Units) by Type (2013-2025)
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume Market Share by Type (Product Category) in 2017
Figure primarily split into Product Picture
Figure Stent Product Picture
Figure PTA Balloon Product Picture
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Comparison (K Units) by Application (2013-2025)
Figure Global Sales Market Share of ICAD (Intracranial Atherosclerotic Disease) Pathology by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Other Examples
Table Key Downstream Customer in Other
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size (Million USD) by Regions (2013-2025)
Figure United States ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Million USD) and Growth Rate (2013-2025)
Figure China ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Million USD) and Growth Rate (2013-2025)
Figure India ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume (K Units) and Growth Rate (2013-2025)
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume (K Units) (2013-2018)
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (K Units) of Key Players/Suppliers (2013-2018)
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Share by Players/Suppliers (2013-2018)
Figure 2017 ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Share by Players/Suppliers
Figure 2017 ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Share by Players/Suppliers
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Players
Table 2017 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Players
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (K Units) and Market Share by Type (2013-2018)
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Share (K Units) by Type (2013-2018)
Figure Sales Market Share of ICAD (Intracranial Atherosclerotic Disease) Pathology by Type (2013-2018)
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate by Type (2013-2018)
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Type (2013-2018)
Figure Revenue Market Share of ICAD (Intracranial Atherosclerotic Disease) Pathology by Type (2013-2018)
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate by Type (2013-2018)
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume (K Units) and Market Share by Region (2013-2018)
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Share by Region (2013-2018)
Figure Sales Market Share of ICAD (Intracranial Atherosclerotic Disease) Pathology by Region (2013-2018)
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate by Region in 2017
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of ICAD (Intracranial Atherosclerotic Disease) Pathology by Region (2013-2018)
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate by Region in 2017
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of ICAD (Intracranial Atherosclerotic Disease) Pathology by Region (2013-2018)
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Region in 2017
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume (K Units) and Market Share by Application (2013-2018)
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of ICAD (Intracranial Atherosclerotic Disease) Pathology by Application (2013-2018)
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application (2013-2018)
Figure United States ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (K Units) and Growth Rate (2013-2018)
Figure United States ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Price (USD/Unit) Trend (2013-2018)
Table United States ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume (K Units) by Players (2013-2018)
Table United States ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume Market Share by Players (2013-2018)
Figure United States ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume Market Share by Players in 2017
Table United States ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume (K Units) by Type (2013-2018)
Table United States ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume Market Share by Type (2013-2018)
Figure United States ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume Market Share by Type in 2017
Table United States ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume (K Units) by Application (2013-2018)
Table United States ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume Market Share by Application (2013-2018)
Figure United States ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume Market Share by Application in 2017
Figure Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (K Units) and Growth Rate (2013-2018)
Figure Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Price (USD/Unit) Trend (2013-2018)
Table Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume (K Units) by Players (2013-2018)
Table Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume Market Share by Players (2013-2018)
Figure Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume Market Share by Players in 2017
Table Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume (K Units) by Type (2013-2018)
Table Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume Market Share by Type (2013-2018)
Figure Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume Market Share by Type in 2017
Table Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume (K Units) by Application (2013-2018)
Table Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume Market Share by Application (2013-2018)
Figure Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume Market Share by Application in 2017
Figure China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (K Units) and Growth Rate (2013-2018)
Figure China ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Million USD) and Growth Rate (2013-2018)
Figure China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Price (USD/Unit) Trend (2013-2018)
Table China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume (K Units) by Players (2013-2018)
Table China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume Market Share by Players (2013-2018)
Figure China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume Market Share by Players in 2017
Table China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume (K Units) by Type (2013-2018)
Table China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume Market Share by Type (2013-2018)
Figure China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume Market Share by Type in 2017
Table China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume (K Units) by Application (2013-2018)
Table China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume Market Share by Application (2013-2018)
Figure China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume Market Share by Application in 2017
Figure Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (K Units) and Growth Rate (2013-2018)
Figure Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Price (USD/Unit) Trend (2013-2018)
Table Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume (K Units) by Players (2013-2018)
Table Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume Market Share by Players (2013-2018)
Figure Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume Market Share by Players in 2017
Table Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume (K Units) by Type (2013-2018)
Table Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume Market Share by Type (2013-2018)
Figure Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume Market Share by Type in 2017
Table Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume (K Units) by Application (2013-2018)
Table Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume Market Share by Application (2013-2018)
Figure Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume Market Share by Application in 2017
Figure Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (K Units) and Growth Rate (2013-2018)
Figure Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Price (USD/Unit) Trend (2013-2018)
Table Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume (K Units) by Players (2013-2018)
Table Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume Market Share by Players in 2017
Table Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume (K Units) by Type (2013-2018)
Table Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume Market Share by Type in 2017
Table Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume (K Units) by Application (2013-2018)
Table Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume Market Share by Application in 2017
Figure India ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (K Units) and Growth Rate (2013-2018)
Figure India ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Million USD) and Growth Rate (2013-2018)
Figure India ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Price (USD/Unit) Trend (2013-2018)
Table India ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume (K Units) by Players (2013-2018)
Table India ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume Market Share by Players (2013-2018)
Figure India ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume Market Share by Players in 2017
Table India ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume (K Units) by Type (2013-2018)
Table India ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume Market Share by Type (2013-2018)
Figure India ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume Market Share by Type in 2017
Table India ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume (K Units) by Application (2013-2018)
Table India ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume Market Share by Application (2013-2018)
Figure India ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume Market Share by Application in 2017
Table Stryker Basic Information List
Table Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate (2013-2018)
Figure Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Global Market Share (2013-2018)
Figure Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Global Market Share (2013-2018)
Table Balt Basic Information List
Table Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate (2013-2018)
Figure Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Global Market Share (2013-2018)
Figure Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Global Market Share (2013-2018)
Table TERUMO Basic Information List
Table TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate (2013-2018)
Figure TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Global Market Share (2013-2018
Figure TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Global Market Share (2013-2018)
Table MicroPort Basic Information List
Table MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate (2013-2018)
Figure MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Global Market Share (2013-2018)
Figure MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Global Market Share (2013-2018)
Table Acandis Basic Information List
Table Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate (2013-2018)
Figure Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Global Market Share (2013-2018)
Figure Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Global Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of ICAD (Intracranial Atherosclerotic Disease) Pathology
Figure Manufacturing Process Analysis of ICAD (Intracranial Atherosclerotic Disease) Pathology
Figure ICAD (Intracranial Atherosclerotic Disease) Pathology Industrial Chain Analysis
Table Raw Materials Sources of ICAD (Intracranial Atherosclerotic Disease) Pathology Major Players in 2017
Table Major Buyers of ICAD (Intracranial Atherosclerotic Disease) Pathology
Table Distributors/Traders List
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price (USD/Unit) and Trend Forecast (2018-2025)
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume (K Units) Forecast by Regions (2018-2025)
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume Market Share Forecast by Regions in 2025
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share Forecast by Regions (2018-2025)
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share Forecast by Regions in 2025
Figure United States ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate Forecast (2018-2025)
Figure China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure China ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure India ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (K Units) Forecast by Type (2018-2025)
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume Market Share Forecast by Type (2018-2025)
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share Forecast by Type (2018-2025)
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price (USD/Unit) Forecast by Type (2018-2025)
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (K Units) Forecast by Application (2018-2025)
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources